Adverse Events of High- vs Low-Dose SGLT2 Inhibitors in T2D Adverse Events of High- vs Low-Dose SGLT2 Inhibitors in T2D

SGLT2 inhibitors are commonly used in the treatment of type 2 diabetes, but they are not without side effects. Are the adverse events associated with these agents dose-related?Journal of Clinical Endocrinology & Metabolism
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news